Gilead Sciences, Inc. vs Ross Stores, Inc. — how do they compare? Gilead Sciences, Inc. trades at $135.28 (market cap $168.35B), while Ross Stores, Inc. trades at $252 (market cap $80.78B). The key difference: Gilead Sciences, Inc. is far larger — about 2.1× Ross Stores, Inc.'s market cap, and Gilead Sciences, Inc. pays the higher dividend (2.42%). Which is the better fit depends on your goals.
| GILD | ROST | |
|---|---|---|
Market Cap | $168.35B | $80.78B |
Sector | Health | Consumer Cyclical |
52-Week High | $155.80 | $255.23 |
52-Week Low | $110.56 | $144.67 |
Enterprise Value | $191.42B | $81.37B |
Dividend Yield | 2.42% | 0.71% |
Trailing returns across standard periods
Latest headlines on both assets
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.
Read more on GILD →Ross Stores is a leading American off-price apparel and home fashion retailer, operating over 1,920 stores (at the end of fiscal 2021) across the Ross Dress for Less and dd's Discounts banners. Ross offers a variety of name-brand products and targets undercutting conventional retailers' regular prices by 20%-70%. The company uses an opportunistic, flexible merchandising approach
Read more on ROST →